Khan SA. Comparative Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Multicenter Propensity-Matched Cohort Study. Int J Med Stud [Internet]. 2026 Aug. 19 [cited 2026 Aug. 30];. Available from: https://ijms.info/IJMS/article/view/4820